Quadrant Capital »

Celldex Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.3k 160 27.16
2025-09-30 $4.1k 160 25.88
2025-03-31 $6.1k 334 18.15
2024-12-31 $1.7k 67 25.28
2022-06-30 $4.0k 132 30.30